
To assess whether zzso prevents body weight gain zzso and zzso dysfunction in patients with schizophrenia who are treated with zzso 

Forty patients taking zzso (10 zzso zzso were randomly allocated to a zzso zzso zzso 20; zzso to zzso zzso zzso or zzso zzso zzso zzso group in a zzso zzso zzso zzso circumference zzso zzso body mass index zzso zzso zzso insulin, and lipids were evaluated at baseline and at Weeks 7 and 14 of zzso 

At Week 14, zzso zzso was similar in the zzso group zzso zzso and the zzso group zzso zzso P zzso zzso There were no differences between the changes in zzso zzso zzso insulin, insulin resistance index zzso and plasma zzso levels observed in the treatment group and the zzso zzso however, zzso levels decreased significantly after zzso administration zzso zzso zzso The zzso decreased significantly in both groups, but 3 subjects from the zzso group developed zzso zzso levels greater than 5 zzso After taking zzso zzso levels increased, but the cholesterol profile improved zzso 

zzso did not prevent zzso zzso While some zzso parameters worsened during zzso the zzso improved in both the zzso and the zzso zzso zzso metabolism impairment was not systematically observed during short-term zzso zzso 

